Stockscreener 앱 받기
3.8813
0.03%
0.0013
전일 마감가:
$3.88
열려 있는:
$3.91
하루 거래량:
20,658
Relative Volume:
0.01
시가총액:
$20.98M
수익:
$15.66M
순이익/손실:
$5.83M
주가수익비율:
-0.1624
EPS:
-23.8939
순현금흐름:
$466.20K
1주 성능:
+4.34%
1개월 성능:
-11.18%
6개월 성능:
-44.71%
1년 성능:
+32.47%
1일 변동 폭
$3.80
$3.98
1주일 범위
$3.645
$3.98
52주 변동 폭
$2.95
$21.40
Neuphoria Therapeutics Inc Stock (NEUP) Company Profile
명칭
Neuphoria Therapeutics Inc
전화
781-439-5551
주소
100 SUMMIT DR, BURLINGTON
NEUP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NEUP
Neuphoria Therapeutics Inc
|
3.902 | 20.86M | 15.66M | 5.83M | 466.20K | -23.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.12 | 115.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
774.28 | 81.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.31 | 52.54B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
851.64 | 51.78B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
174.05 | 37.12B | 447.02M | -1.18B | -906.14M | -6.1812 |
Neuphoria Therapeutics Inc Stock (NEUP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-09-28 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2023-09-28 | 재확인 | Maxim Group | Buy |
| 2022-01-10 | 개시 | Berenberg | Buy |
| 2022-01-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-01-10 | 개시 | Evercore ISI | Outperform |
| 2022-01-10 | 개시 | H.C. Wainwright | Buy |
모두보기
Neuphoria Therapeutics Inc 주식(NEUP)의 최신 뉴스
Aug Intraday: Will Neuphoria Therapeutics Inc stock outperform Dow Jones indexShare Buyback & Low Risk Growth Stock Ideas - moha.gov.vn
Neuphoria Therapeutics Inc. (NEUP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Weekly Recap: Why Neuphoria Therapeutics Inc. stock could outperform in 2025Insider Buying & Free Fast Entry Momentum Trade Alerts - ulpravda.ru
What risks investors should watch in Neuphoria Therapeutics Inc. stockMarket Activity Recap & Fast Entry High Yield Stock Tips - bolumsonucanavari.com
Published on: 2025-12-20 20:44:19 - Улправда
Published on: 2025-12-20 15:41:19 - Улправда
Why Neuphoria Therapeutics Inc. stock remains on watchlistsIPO Watch & Weekly Return Optimization Alerts - Улправда
How buybacks impact Neuphoria Therapeutics Inc. stock valueInsider Selling & AI Forecast Swing Trade Picks - Улправда
Will Neuphoria Therapeutics Inc. stock remain a Wall Street favoriteJuly 2025 Chart Watch & Daily Entry Point Alerts - DonanımHaber
How Neuphoria Therapeutics Inc. stock reacts to global recession fears2025 Volume Leaders & AI Optimized Trade Strategies - Улправда
Is Neuphoria Therapeutics Inc. stock positioned for digital transformationWeekly Risk Summary & Weekly Stock Breakout Alerts - DonanımHaber
Does Neuphoria Therapeutics Inc. stock trade at a discount to peersWeekly Trend Summary & Smart Investment Allocation Insights - DonanımHaber
How Neuphoria Therapeutics Inc. stock benefits from global expansionJuly 2025 Drop Watch & Accurate Buy Signal Notifications - DonanımHaber
Neuphoria Therapeutics (NEUP) details 2025 annual meeting and vote outcomes - Stock Titan
Neuphoria Therapeutics (NASDAQ:NEUP) Cut to Strong Sell at Zacks Research - Defense World
Abeona Therapeutics (NASDAQ:ABEO) and Neuphoria Therapeutics (NASDAQ:NEUP) Critical Comparison - Defense World
ISS recommends shareholders vote for Neuphoria’s board nominees By Investing.com - Investing.com Australia
Leading Advisory Firms Recommend Voting FOR Lynx1's Independent Nominees - Yahoo Finance
Institutional Shareholder Services Recommends Shareholders of Neuphoria to Vote for its Director Nominees - marketscreener.com
ISS recommends shareholders vote for Neuphoria’s board nominees - Investing.com
Neuphoria Therapeutics (NEUP) Gains ISS Support for Director Nom - GuruFocus
Leading Proxy Advisory Firm ISS Recommends that Shareholders Vote the WHITE Proxy Card FOR Both of Neuphoria’s Director Nominees - The Manila Times
HC Wainwright Has Lowered Expectations for Neuphoria Therapeutics (NASDAQ:NEUP) Stock Price - Defense World
Analysts Are Bullish on Top Healthcare Stocks: Adicet Bio (ACET), Palvella Therapeutics (PVLA) - The Globe and Mail
Neuphoria Therapeutics (NEUP) Stock Analysis Report | Financials & Insights - Benzinga
HC Wainwright & Co. Maintains Neuphoria Therapeutics (NEUP) Buy Recommendation - Nasdaq
NEUP: Analyst Lowers Price Target by 66% but Maintains 'Buy' Rat - GuruFocus
Neuphoria continues strategic review amid reduced takeover offer By Investing.com - Investing.com Nigeria
Will Neuphoria Therapeutics Inc. stock deliver strong dividend growthIPO Watch & Weekly Watchlist for Hot Stocks - Newser
Neuphoria Therapeutics (NEUP) Considers Strategic Alternatives A - GuruFocus
Neuphoria continues strategic review amid reduced takeover offer - Investing.com
Neuphoria responds to Lynx1's revised indication of interest at a reduced price and premium - marketscreener.com
Neuphoria Responds to Lynx1’s Revised Indication of Interest at a Reduced Price and Premium - The Manila Times
Is Neuphoria Therapeutics Inc. stock near bottom after declineEarnings Risk Report & Weekly Top Stock Performers List - Newser
Lynx1 Master Sends a Letter to the Shareholders of Neuphoria Therapeutics - marketscreener.com
Lynx1 Sends Open Letter to Fellow Neuphoria Shareholders - Yahoo Finance
Neuphoria Therapeutics Inc (NEUP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.66%
2.07%
자본화:
|
볼륨(24시간):